TIMOTHY WEST: Open Payments
NPI 1629778998 · KINSTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$253 in 12 payments from 10 companies in 2025. Trend: 2023 $547 · 2024 $409 · 2025 $253
Food & beverage: $253
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| Amgen Inc. | 2 | $39 |
| Calliditas Therapeutics US Inc. | 1 | $30 |
| Novo Nordisk Inc | 1 | $26 |
| Travere Therapeutics, Inc. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| SCPHARMACEUTICALS INC. | 1 | $20 |
| Alexion Pharmaceuticals, Inc. | 1 | $20 |
| Mallinckrodt Hospital Products Inc. | 1 | $17 |
| Fresenius USA Marketing, Inc. | 1 | $15 |
Products named: TARPEYO, Ozempic, Vanrafia, KRYSTEXXA, BRILINTA, FUROSCIX, ULTOMIRIS, ACTHAR.
Industry payments across NC — which companies pay providers there.
